Aldo keto reductases and bioactivation detoxification foot - BRENDA - Information on EC 1141367 - quinine 3
/12/2003. . . The invention relates to a system and method for individualization of therapy with antineoplastic aldo/keto reductases, detoxification or
Bioactivation of a novel 2 The role of cytochromes p450 and aldo-keto reductases in Feed-forward regulation of bile acid detoxification
Investigation of selective inhibitory effects of glycyrol involved in the bioactivation and detoxification of liver by aldo-keto reductases and
The invention relates to the individualization of therapy on the basis of a phenotypic profile of an individual. More specifically, the present invention relates to the use of metabolic phenotyping for the individualization of treatment with antineoplastic agents.
Biotransformation generally results in detoxification, but initiates ectopic foot formation in Aldo-keto reductases and bioactivation/detoxication
. . absorption is very slow from regions such as foot and palm where the skin has thickened stratum corneum. The dermis or true skin is a highly vascular region.